Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans

H Wang1,2, B Liu1,2, A Q O Al-Aidaroos3

  • 1Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.

Oncogene
|October 13, 2015
PubMed

Insights

A novel protein, Src homology 3 (SH3) domain-binding glutamic acid-rich-like protein (SH3BGRL), activates c-Src to promote cancer metastasis in mice. However, human SH3BGRL suppresses metastasis, with specific mutations restoring its oncogenic function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • c-Src is a known oncogene promoting metastasis, but activating mutations are rare.
  • Trans-acting proteins are implicated in regulating c-Src activation.
  • The role of SH3BGRL in cancer has not been previously defined.

Purpose of the Study:

  • To identify novel regulators of c-Src activation.
  • To investigate the role of SH3BGRL in cancer metastasis.
  • To explore the differential functions of murine and human SH3BGRL.

Main Methods:

  • Discovery and characterization of murine SH3BGRL (mSH3BGRL).
  • Assays for tumor cell invasion and lung metastasis.
  • Molecular analysis of c-Src phosphorylation and downstream signaling pathways (FAK, ERK, AKT).
  • Site-specific mutation analysis of human SH3BGRL (hSH3BGRL).

Main Results:

  • Ectopic mSH3BGRL expression promoted tumor cell invasion and lung metastasis.
  • mSH3BGRL binds inactive c-Src, promoting its activation and downstream signaling.
  • Targeting c-Src abolished mSH3BGRL-induced metastasis.
  • hSH3BGRL suppressed tumorigenesis and metastasis.
  • A V108A substitution in hSH3BGRL restored its oncogenic function.
  • The somatic mutation R76C in hSH3BGRL also promoted tumorigenesis and metastasis.

Conclusions:

  • SH3BGRL has an evolutionarily divergent role in cancer metastasis via c-Src activation.
  • Murine SH3BGRL acts as a c-Src activator promoting metastasis.
  • Human SH3BGRL generally suppresses metastasis, but specific mutations confer oncogenic activity.
  • SH3BGRL mutation status may be relevant for cancer diagnosis and therapy.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.9K